# EDGAR Filing Document

**Accession Number:** 0001844392
**File Stem:** 0000950170-23-001979
**Filing Date:** 2023-2
**Character Count:** 11452
**Document Hash:** 301f5a996f01ccc1b4af009f4aa811aa
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950170-23-001979.hdr.sgml**: 20230207

**ACCESSION NUMBER**: 0000950170-23-001979

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230201

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230207

**DATE AS OF CHANGE**: 20230207

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Marpai, Inc.
- **CENTRAL INDEX KEY:** 0001844392
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40904
- **FILM NUMBER:** 23595004

**BUSINESS ADDRESS:**
- **STREET 1:** 5701 EAST HILLSBOROUGH AVENUE, SUITE 141
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33610
- **BUSINESS PHONE:** 646-303-3483

**MAIL ADDRESS:**
- **STREET 1:** 5701 EAST HILLSBOROUGH AVENUE, SUITE 141
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33610

?xml version="1.0" encoding="ASCII"? 8-K

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549**

------

**FORM** 8-K

------

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported):** February 01, 2023<br>

------

MARPAI, INC.

**(Exact name of Registrant as Specified in Its Charter)**

------

---

| | | |
|:---|:---|:---|
| Delaware | 001-40904 | 86-1916231 |
| **(State or Other Jurisdiction<br>of Incorporation)** | **(Commission File Number)** | **(IRS Employer<br>Identification No.)** |
| 5701 East Hillsborough Avenue, Suite 1417 |  |  |
| Tampa**,** Florida |  | 33610 |
| **(Address of Principal Executive Offices)** |  | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code:** 646 303-3483<br>

**(Former Name or Former Address, if Changed Since Last Report)**

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **<br>Title of each class** | **Trading<br>Symbol(s)** | **<br>Name of each exchange on which registered** |
| Class A Common Stock, par value $0.0001 per share | MRAI | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

------

**Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

Effective February 1, 2023, Ronnie S. Brown resigned as the Chief Operating Officer of Marpai, Inc. (the "Company"). Ms. Brown did not resign as a result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices and will continue to provide consulting services to the Company.

**Item 8.01 Other Events.**

On February 7, 2023, the Company issued a press release titled, "Marpai Hires Gonen Antebi as Chief Operating Officer." A copy of the press release is attached as Exhibit 99.1 hereto and is incorporated by reference herein.

**Item 9.01 Financial Statements and Exhibits.**

(d) Exhibits.

---

| | |
|:---|:---|
| Exhibit<br>Number | Description |
| 99.1 | [<u>Press release dated February 7, 2023.</u>](mrai-ex99_1.htm) |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  |  | MARPAI, INC. |
| Date: | February 7, 2023 | By:  | /s/ Edmundo Gonzalez |
|  |  |  | Name: Edmundo Gonzalez<br>Title: Chief Executive Officer |

---

------

## Exhibit 99.1

Exhibit 99.1

![img155121336_0.jpg](img155121336_0.jpg)

FOR IMMEDIATE RELEASE

**Marpai Hires Gonen Antebi as Chief Operating Officer** 

Seasoned healthtech leader with a track of profitable growth to lead Company's TPA businesses

NEW YORK, Feb. 7, 2023 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an AI-technology company transforming self-funded employer health plans, has hired Gonen Antebi as its Chief Operating Officer. Most recently, Mr. Antebi has served as the Chief Executive Officer of Nuvem Health <u>("Nuvem")</u>, where he created the teams, technology and processes that drove a small start-up into an industry leader in just seven years. Prior to Nuvem, Mr. Antebi gained vast experience in healthcare data and third-party administration serving as Chief Operating Officer at ArroHealth and as Chief Executive Officer of MedSave USA, Inc.

"Gonen is the best operator I have met in my career," stated Marpai co-founder and Chief Executive Officer Edmundo Gonzalez. "Six years ago he took a healthcare tech start-up, where I was a founding partner, and created a highly profitable business with significant scale. He has created hundreds of millions of dollars in shareholder value, and I'm delighted to have him on our team." Nuvem was sold to a large private equity firm in 2020, and Mr. Antebi stayed on as its Chief Executive Officer until recently. He has served as a director on Marpai's board of directors since October 2021, where he also chaired the audit committee of the board of directors (the "Audit Committee"). He resigned from his board position prior to his start as Chief Operating Officer of Marpai.

Mr. Antebi is leading all operations and running Marpai's third-party administrator (TPA) business, which has been built via two acquisitions, including the recently-announced acquisition of Maestro Health. He is replacing industry veteran Ronnie Brown, who has served as Marpai's Chief Operating Officer since 2021. "I know I speak for everyone, when I say thank you to our former Chief Operating Officer, Ronnie Brown, who I brought out of retirement as a trusted operating partner on this journey of building Marpai. Ronnie is a healthcare industry treasure. She will continue to advise us on key strategic and operating issues," says Mr. Gonzalez.

Marpai is transforming self-funded employer health plans with exclusive data-driven, AI-powered products that maximize member population health and reduce medical and medication costs. The exclusive Marpai services work to help members act early, stay on the

------

best health journey and avoid overpriced, excessive and inappropriate care and medications which delivers significant savings to employer health plans. Integrating leading edge technologies to modernize traditional TPA services like claims processing and launch new tech-enabled services demands a new kind of operational framework. Yaron Eitan, co-founder and Chairman of Marpai, says, "Gonen is a master of taking complex operations and making them run smoothly and, best of all, profitably. We believe that he is perfect for where Marpai is now as it moves towards scalable profitability."

Learm more at www.Marpaihealth.com or https://ir.marpaihealth.com.

**About Marpai, Inc.**

Marpai, Inc. (Nasdaq: MRAI) is an AI-powered technology company creating better health plans with lower costs for employers that directly pay for employee health benefits (self-funded employer health plans). Marpai primarily competes in the $22 billion TPA (Third Party Administrator) sector serving self-funded health plans representing over $1 trillion in annual claims. The company commits to delivering the healthiest member population with the greatest cost efficiency for any health plan budget. In addition to standard TPA services, including access to the Aetna and Cigna provider networks, Marpai delivers exclusive services that help members access high quality care, stay on track with annual care, act early and steer clear of inappropriate, overpriced and excessive care and medications.

For more information, visit www.marpaihealth.com.

**Forward-Looking Statement Disclaimer** 

This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties, including statements regarding revenues, employee lives and cash. Forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "guidance," "may," "can," "could", "will", "potential", "should," "goal" and variations of these words or similar expressions. For example, the Company is using forward looking statements when it discusses that Ms. Brown will continue to advise the Company on key strategic and operating issues, its transformation of self-funded employer health plans, advantages and benefits of its products and its move towards scalable profitability. Readers are cautioned not to place undue reliance on these forward-looking statements, which

------

reflect Marpai's current expectations and speak only as of the date of this release. Actual results may differ materially from Marpai's current expectations depending upon a number of factors. These factors include, among others, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business. Except as required by law, Marpai does not undertake any responsibility to revise or update any forward-looking statements whether as a result of new information, future events or otherwise. More detailed information about Marpai and the risk factors that may affect the realization of forward-looking statements is set forth in Marpai's filings with the Securities and Exchange Commission (SEC). Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov.

**Media contact:**<br> Danielle Belding-Smith for Marpai<br>dbsmith@marpaihealth.com

(704) 562-8953

**Investor Relations contact:**<br> Simon Li<br>simonli@marpaihealth.com<br>(813) 822-3950

SOURCE Marpai, Inc.

Released January 31, 2023

------